LYTIR

Company · MDWD

MediWound Ltd.

Nasdaq's symbol directory lists MDWD on Nasdaq as “MediWound Ltd. - Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($7K); insiders sold on 3 occasions ($82K); 2 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $7K in total; Insider sales: $82K in total.Aug: Insider sales $75KSep: Insider purchases $7KSep: Insider sales $7KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $7KInsider sales below: $82K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Hess Shmuel, COO & Chief Commercial Officer sold on 2 days latest Aug 27, 2026 sold $75K
  2. Rubinstein Samuel sold on 1 day bought on 1 day latest Sep 1, 2026 sold $7K · bought $7K
Every trade (4)
  1. SELLRubinstein Samuel sold Sep 1, 2026 525 shares filing $7K
  2. BUYRubinstein Samuel bought Sep 1, 2026 525 shares filing $7K
  3. SELLHess Shmuel, COO & Chief Commercial Officer sold Aug 27, 2026 3,958 shares 2 legs combined filing $51K
  4. SELLHess Shmuel, COO & Chief Commercial Officer sold Aug 26, 2026 1,865 shares filing $24K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. HOLD Alapkezelo Zrt. filed Aug 28, 2026 Schedule 13G/A passive filing 10.4%
  2. T. Rowe Price Associates, Inc. filed Aug 14, 2026 Schedule 13G/A passive 641,075 shares filing 5%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.